Expression of lactate dehydrogenase C in MDA-MB-231 cells and its role in tumor invasion and migration

被引:30
|
作者
Kong, Lingying [1 ]
Du, Wei [1 ]
Cui, Zhaolei [2 ]
Wang, Li [1 ]
Yang, Zhi [1 ]
Zhang, Hongsheng [1 ]
Lin, Donghong [2 ]
机构
[1] Fujian Univ Tradit Chinese Med, Affiliated Peoples Hosp, Dept Pathol, 602 817 Zhong Rd, Fuzhou 350004, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Clin Lab, Sch Med Technol & Engn, Fuzhou 350004, Fujian, Peoples R China
关键词
lactate dehydrogenase C; breast cancer; MDA-MB-231; invasion; migration; CANCER-CELLS; LDH-A; GENE; SPERM; METABOLISM; INHIBITORS; APOPTOSIS; ANALOGS; TARGET; GROWTH;
D O I
10.3892/mmr.2016.4963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cancer/testis antigen (CTA) lactate dehydrogenase C (LDHC) is a unique LDH isoenzyme associated with glucose and adenosine triphosphate production in mammalian germ cells. However, the role of LDHC in cancer has thus far largely remained elusive. The present study described the expression status of LDHC in human MDA-MB-231 breast cancer cells as well as its role in tumor invasion and migration. Immunohistochemical analysis revealed endogenous LDHC expression in the cytoplasm and nuclei of MDA-MB-231 cells yielded. In addition, in vitro cell invasion and migration assays revealed that when LDHC expression was blocked by its specific inhibitor, cell invasion and migration were compromised in MDA-MB-231 cells. Of note, inhibition of LDHC was unable to induce apoptosis in MDA-MB-231 cells. The present study provided evidence that the LDHC enzyme acts as a CTA in breast carcinoma and exerts an essential role in tumor invasion and migration.
引用
收藏
页码:3533 / 3538
页数:6
相关论文
共 50 条
  • [1] Brazilein suppresses migration and invasion of MDA-MB-231 breast cancer cells
    Hsieh, Chi-Ying
    Tsai, Pei-Chien
    Chu, Chiao-Lun
    Chang, Fang-Rong
    Chang, Long-Sen
    Wu, Yang-Chang
    Lin, Shinne-Ren
    CHEMICO-BIOLOGICAL INTERACTIONS, 2013, 204 (02) : 105 - 115
  • [2] A cyclometalated iridium(III) complex that inhibits the migration and invasion of MDA-MB-231 cells
    Wang, Jinquan
    Hou, Xiaojuan
    Zhao, Zizhuo
    Bo, Huaben
    Chen, Qizhu
    INORGANIC CHEMISTRY COMMUNICATIONS, 2016, 67 : 40 - 43
  • [3] Role of different cathepsins in the invasion of MDA-MB-231 human breast cancer cells
    Gautam, Jaya
    Kim, Jung-Ae
    FASEB JOURNAL, 2014, 28 (01):
  • [4] Combined effects of pioglitazone and doxorubicin on migration and invasion of MDA-MB-231 breast cancer cells
    Parisa Malakouti
    Mobin Mohammadi
    Mohammad Amin Boshagh
    Abbasali Amini
    Mohammad Ali Rezaee
    Mohammad Reza Rahmani
    Journal of the Egyptian National Cancer Institute, 34
  • [5] Secreted factors, identified as exosomes, enhance proliferation, migration, and invasion in MDA-MB-231 cells
    Cunningham, Terri
    Yearby, Letitia A.
    Garrett, Destane
    FASEB JOURNAL, 2016, 30
  • [6] Combined effects of pioglitazone and doxorubicin on migration and invasion of MDA-MB-231 breast cancer cells
    Malakouti, Parisa
    Mohammadi, Mobin
    Boshagh, Mohammad Amin
    Amini, Abbasali
    Rezaee, Mohammad Ali
    Rahmani, Mohammad Reza
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2022, 34 (01)
  • [7] Alisol A Suppresses Proliferation, Migration, and Invasion in Human Breast Cancer MDA-MB-231 Cells
    Lou, Chenghua
    Xu, Xintong
    Chen, Yan
    Zhao, Huajun
    MOLECULES, 2019, 24 (20):
  • [8] Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells
    Tsai, Pei-Chien
    Chu, Chiao-Lun
    Chiu, Chien-Chih
    Chang, Long-Sen
    Lin, Shinne-Ren
    TOXICON, 2013, 74 : 56 - 67
  • [9] Fibroblast growth factor 18 promotes the growth, migration and invasion of MDA-MB-231 cells
    Yu, Ziyi
    Lou, Longquan
    Zhao, Yi
    ONCOLOGY REPORTS, 2018, 40 (02) : 704 - 714
  • [10] Propofol inhibited invasion and decreased expression of PMEPA1 in MDA-MB-231 cells
    Zhou, Quan
    Tao, Tao
    Fun, Jun
    Luo, Cong
    Zhu, Chen
    Qin, Zai-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (10): : 14331 - +